- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Emergence of unusual human rotavirus strains in Salento, Italy, during 2006–2007
© De Donno et al; licensee BioMed Central Ltd. 2009
Received: 21 July 2008
Accepted: 15 April 2009
Published: 15 April 2009
In recent years, rotavirus genotyping by RT-PCR has provided valuable information about the diversity of rotaviruses (RV) circulating throughout the world.
The purpose of the present study was to monitor the prevalence of the different G and P genotypes of rotaviruses circulating in Salento and detect any uncommon or novel types.
During the period from January 2006 to December 2007, a total of 243 rotavirus positive stool samples were collected from children with diarrhoea admitted to four Hospitals in the province of Lecce (Copertino, Galatina, Gallipoli and Tricase).
All the specimens were tested for RV by real time PCR and genotyped for VP7 (G-type) and VP4 (P-type) gene by reverse transcription (RT) and multiplex PCR using different type specific primers.
In course of this study we identified 4 common G&P combinations viz. G2P, G1P, G2P and G9P amongst 59.8% of the typeable rotavirus positives.
Rotavirus G2P was recognized as the most widespread genotype during the sentinel-based survey in Salento.
The detection of other novel and unusual strains, such as G2P, G4P, G8P, G9P and G10P is noteworthy.
Furthermore, a significant number of mixed infections were observed during the survey period but G3P rotaviruses were not detected.
This study highlights the genetic diversity among rotaviruses isolated from children in Salento and the emergence of some novel strains. Therefore, it is highly essential to continuously monitor for these strains so as to assess the impact of vaccines on RV strains circulating in Salento and understand the effect of strain variation on efficacy of presently available vaccines.
Rotavirus (RV), the most common cause of gastroenteritis in infants and young children, presents a capsid formed by three concentric layers. The outer protein layer is composed of VP4 and VP7, the two major antigens of the virus, and the middle layer is composed of VP6 molecules arranged as trimers. The central core is composed mainly of VP2 and contains 11 segments of double-stranded RNA and enzyme complexes responsible for the processes of RNA transcription and replication .
As the two gene segments that encode the outer capsid proteins (VP4 and VP7) segregate independently, a typing system consisting of both G and P genotypes has been developed. To date, 15 G and 26 P genotypes have been described [2, 3].
Worldwide surveillance of RV strains has demonstrated G1 to G4 genotypes with P and P genotypes to be the most common circulating RV [5, 6]. However, several recent international studies have reported some unusual types (G5, G8 and G12) and rare combinations of G and P types [6–10].
G12 strains, in particular, had been detected during the previous study in 2004 in Salento and nucleotide sequences were deposited in database with accession numbers EF536025 and EF536026 respectively .
Surveillance studies and documentation of rotavirus G and P genotypes is necessary for comprehensive evaluation of evolution of new strains and assessing the capability of vaccines to provide heterotypic protection.
The objective of this study was to monitor the prevalence of the different G and P types circulating in Salento and to detect uncommon and novel types.
This report highlights the results gathered during the ongoing sentinel-based network surveillance in hospitals of Salento having a paediatric ward, since 2004, to understand the molecular epidemiological changes amongst rotaviruses in relation to their G and P genotypes .
From January 2006 to December 2007, a total of 243 rotavirus-positive stool specimens were collected during the course of treatment from children under 16 years of age hospitalized with gastro-enteric symptoms in four hospitals in the province of Lecce, specifically Copertino, Galatina, Gallipoli and Tricase.
The routine diagnosis for RV infection was carried out in the Clinical Virology Laboratories of the hospitals by means of rapid screening tests currently available in the market, such as latex agglutination (ROTAGEN, Biokit) and immuno-chromatographic (ROTA-STRIP QUICK-TEST, Amplimedical) tests. According to the producers, these tests have a sensitivity and specificity ranging between 95.7–100% and 96.3–100%, respectively. RV-positive specimens were collected anonymously in compliance with the Helsinki Declaration and with the Law Decree n. 196/2003, article 24 (Code for the protection of personal data). Furthermore, in this study was not performed any experimental work on patients, therefore the Ethics Committee of Ferrara (Italy) declared that this form of study doesn't need any consent by the Ethic Committee in compliance with the Italian Law.
The specimens were stored at -20°C until tested by molecular biology techniques.
The faecal samples (0.5–1 ml) were diluted to approx. 5 ml of 0.89% NaCl; centrifugated for 20 min at 3000 rpm and filtered using a 0.22 μm filter.
Rotavirus double-stranded RNA was extracted using the QIAamp Viral RNA kit (QIAGEN AG, Basel, Switzerland) according to the manufacturer's instructions.
The RNA was retro-transcribed and amplified by real-time PCR (Fastset Rotavirus; Arrows Diagnostics, Italy).
Reverse transcription with random primers and G and P typing semi-nested multiplex PCR were performed as described previously by Iturriza-Gomara et al .
The consensus primers (VP7-F/VP7-R and con2/con3) were used in multiplex first round reactions and type-specific primers (G1–G4, G8–G10 and P, P, P–P) were used in the second round reactions.
All the RT-PCRs were performed with viral RNA extracted from reference samples as positive controls and RNase free water as negative control.
RT-PCR fragments were electrophoresed in 2% agarose gels in Tris-borate-EDTA buffer along with a 100-bp or 50-bp DNA ladder (PROMEGA) as a standard marker. The gels were stained with ethidium bromide and amplicons were viewed with UV light.
A total of 243 stool samples were collected from children with acute gastroenteritis during 2006 (n = 108) and 2007 (n = 135).
The genotype nature of RV positive specimens
Rotavirus positive specimens minus untypeable
Only G typed
Only P typed
G & P typed
108-3 = 105
135-4 = 131
243-7 = 236
Distribution of RV mixed infections during 2006–2007
Strains with given genotype
G mixed infections
G1 G2 G8
G1 G2 G9
G2 G4 G10
G2 G9 G10
P mixed infections
Molecular analysis of the VP7 gene revealed the prevalence of six different G-genotypes in Salento.
In particular, study data from this 2-year investigation indicates that the G2 rotavirus continue to be the most prevalent genotype as it was in the previous surveillance study conducted between 2004–2005 in Salento .
Moreover, our study confirmed the persistence of rotaviruses G9, identified in this area since 2004 . Genotype G9, previously infrequently reported, has become quite common all over the world . An increased prevalence of the G9 genotype has also been noted in Italy [15, 16]. This result reinforces the possibility that G9 may represent the fifth globally important genotype to be considered in vaccination programs.
Furthermore, this study documents the first detection of G8 and G10 strains in Salento. These strains (normally associated with animals) have been sporadically recovered from humans in various geographical areas. Genotype G8 strains were first reported from young children with gastroenteritis in Indonesia . Later these rotaviruses were also reported from Finland, Italy, Nigeria, Brazil [18–21] and other parts of the African continent, especially Malawi [22, 23].
RV G10 genotype was first isolated in the UK in 1992 but recent epidemiological surveys have reported the presence of this strain in India .
With respect to VP4 gene, six different P-types were identified; P was the prevalent type while P, P and P were detected for the first time in Salento.
At present, worldwide, five common G/P combinations of RV predominate, namely G1P, G2P, G3P, G4P and G9P [5, 9, 14]. Global reviews of the main G and P type combinations encountered in human infections have identified G1P as the most prevalent type .
In this research, only 4 of the most common G/P combinations were identified (no G3P was found), representing 59.8% of the typeable RV samples. However, G2P was the most prevalent combination during 2006–2007, while G1P was predominant one in 2007.
G2P is a new and unusual G/P combination that in recent years (with G1P and G4P) has been detected at relatively high frequency from different parts of the world .
The detection of uncommon strains, such as G2P, G4P, G8P, G9P and G10P, is significant.
Finally, according to multiplex PCR results, a lot of mixed infections, especially in the G-types, were identified. These mixed infections most likely represent naturally occurring reassortment among RV strains [4, 5, 25]. Anyway, the use of multiplex PCR in the identification of mixed infectious should be handled with caution. The possibility of unspecific primer binding has to be taken into consideration. Furthermore, in mixed infections the rotavirus strains might be present at different concentrations, resulting in an uneven degree of PCR amplification, making the interpretation of the gel band pattern difficult [26, 27].
In light of these considerations, additional experiments are necessary to confirm the results obtained during G and P typing. In particular, the confirmation of the high frequency of unusual G/P combinations found by sequence analysis is recommended.
The diversity of strains circulating in different regions may be important for vaccine administration and development. Two live oral vaccines have recently been licensed to protect children against RV diarrhea: Rotateq, a human-bovine pentavalent vaccine, and Rotarix, a G1P monovalent human rotavirus vaccine [28, 29].
Clinical trials of these vaccines among children of rich and middle-income families in different countries have demonstrated high efficacy against the most common RV strains.
Anyway, the importance of heterotypic protection has to be fully understood; for this reason, virological surveillance and strain characterization should be implemented.
Post-marketing surveillance studies are needed to monitor the vaccine impact on circulating strains in order to evaluate the immunological pressure obtained by vaccination, to identify if strain replacement occurs, and to measure the extent of cross-protection against different RV genotypes, including G9 (which is becoming increasingly important in the world) and G8 (whose prevalence is increasing in different parts of Africa), as these G types were also detected in Salento.
The authors are grateful to the "Members of the Collaborative Group for the surveillance of Rotavirus Infection": E. Errico, "S. Caterina Novella" Hospital – Galatina (Le); C. Lanzillotto, "S. Giuseppe da Copertino" Hospital – Copertino (Le); L. Morciano, "Cardinale G. Panico" Hospital – Tricase (Le); G. Pepe, "Sacro Cuore di Gesù" Hospital – Gallipoli (Le).
This work was performed at the Department of Biological and Environmental Sciences and Technologies, Lab of Hygiene, University of Salento, Italy.
This study was funded by a grant from PRIN (Scientific Reasearch Programs of National Relevance) Research Programme 2005–2007 (Ministry of Education, University and Research): "Epidemiological pattern of viral gastroenteritis and rotavirus vaccination".
- Kapikian AZ, Hoshino Y, Chanock RM: Rotaviruses. Fields virology. Edited by: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE. 2007, Lippincott Williams and Wilkins, Philadelphia, PA, 2: 1787-1834. 5Google Scholar
- Rahaman M, Matthijnssens J, Goegebuer T, De Leener K, Vanderwegen L, Donck van der I, Van Hoovels L, De Vos S, Azim T, Van Ranst M: Predominance of rotavirus G9 genotype in children hospitalized for rotavirus gastroenteritis in Belgium during 1999–2003. J Clin Virol. 2005, 33: 1-6. 10.1016/j.jcv.2004.09.020.View ArticleGoogle Scholar
- Martella V, Ciarlet M, Banyai K, Lorusso E, Cavalli A, Corrente M, Elia G, Arista S, Camero M, Desario C, Decaro N, Lavazza A, Buonavoglia C: Identification of a novel VP4 genotype carried by a serotype G5 porcine rotavirus strain. Virology. 2006, 346: 301-311. 10.1016/j.virol.2005.11.001.View ArticlePubMedGoogle Scholar
- Maunula L, von Bonsdorff CH: Frequent reassortments may explain the genetic heterogeneity of rotaviruses: analysis of Finnish rotavirus strains. J Virol. 2002, 76: 11793-11800. 10.1128/JVI.76.23.11793-11800.2002.View ArticlePubMedPubMed CentralGoogle Scholar
- Santos N, Hoshino Y: Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005, 15: 29-56. 10.1002/rmv.448.View ArticlePubMedGoogle Scholar
- Castello AA, Arguelles MH, Rota RP, Olthoff A, Jiang B, Glass RI, Gentsch JR, Glikmann G: Molecular epidemiology of group A rotavirus diarrhea among children in Buenos Aires, Argentina, from 1999 to 2003 and emergence of the infrequent genotype G12. J Clin Microbiol. 2006, 44: 2046-2050. 10.1128/JCM.02436-05.View ArticlePubMedPubMed CentralGoogle Scholar
- Adah MI, Wade A, Taniguchi K: Molecular epidemiology of rotaviruses in Nigeria: detection of unusual strains with G2P and G8P specificities. J Clin Microbiol. 2001, 39: 3969-75. 10.1128/JCM.39.11.3969-3975.2001.View ArticlePubMedPubMed CentralGoogle Scholar
- Cunliffe NA, Bresee JS, Gentsch JR, Glass RI, Hart CA: The expanding diversity of rotavirus. Lancet. 2002, 359: 640-2. 10.1016/S0140-6736(02)07781-4.View ArticlePubMedGoogle Scholar
- Van Damme P, Giaquinto C, Maxwell M, Todd P, Wielen Van der M, on behalf of the REVEAL Study Group: Distribution of Rotavirus Genotypes in Europe, 2004–2005: The REVEAL Study. J Infect Dis. 2007, 195 (Suppl 1): 17-25. 10.1086/516715.View ArticleGoogle Scholar
- Sharma S, Ray P, Gentsch JR, Glass RI, Kalra V, Bhan MK: Emergence of G12 Rotavirus strains in Delhi, India, in 2000 to 2007. J Clin Microbiol. 2008, 46: 1343-1348. 10.1128/JCM.02358-07.View ArticlePubMedPubMed CentralGoogle Scholar
- Grassi T, De Donno A, Guido M, Gabutti G, the Collaborative Group for the surveillance of Rotavirus Infection: G-genotyping of rotaviruses in stool samples in Salento, Italy. J Prev Med Hyg. 2006, 47 (4): 138-141.PubMedGoogle Scholar
- De Donno A, Grassi T, Idolo A, Gabutti G, Guido M, the Collaborative Group for the Surveillance of Rotavirus Infection: The epidemiology of rotavirus infection and the distribution of G-types in Salento (Italy) during 2004–2005. International Journal of Health Science (IJHS). 2008, 1: 26-29.Google Scholar
- Iturriza-Gomara M, Kang G, Gray J: Rotavirus genotyping: keeping-up with an evolving population of human rotaviruses. J Clin Virol. 2004, 31: 259-365. 10.1016/j.jcv.2004.04.009.View ArticlePubMedGoogle Scholar
- Desselberger U, Wolleswinkel-van den Bosch J, Mrukowicz J, Rodrigo C, Giaquinto C, Vesikari T: Rotavirus types in Europe and their significance for vaccination. Pediatr Infect Dis J. 2006, 25: S30-41. 10.1097/01.inf.0000197707.70835.f3.View ArticlePubMedGoogle Scholar
- Arista S, Giammanco GM, De Grazia S, Migliore MC, Martella V, Cascio A: Molecular characterization of the genotype G9 human rotavirus strains recovered in Palermo, Italy, during the winter of 1999–2000. Epidemiol Infect. 2004, 132: 343-349. 10.1017/S0950268803001602.View ArticlePubMedPubMed CentralGoogle Scholar
- Ansaldi F, Pastorino B, Valle L, Durando P, Sticchi L, Tucci P, Biasci P, Lai P, Gasparini R, Icardi G, the Paediatric Leghorn Group: Molecular Characterization of a New Variant of Rotavirus PG9 Predominant in a Sentinel-based Survey in Central Italy. J Clin Microbiol. 2007, 45: 1011-1015. 10.1128/JCM.02054-06.View ArticlePubMedGoogle Scholar
- Matsuno S, Hasewaga A, Mukoyama A, Inouye S: A candidate for a new serotype of human rotavirus. J Virol. 1985, 54: 623-624.PubMedPubMed CentralGoogle Scholar
- Gerna G, Sarasini A, Arista S, Di Matteo A, Giovannelli L, Parea M, Halonen P: Prevalence of human rotavirus serotypes in some European countries. Scand J Infect Dis. 1990, 22: 5-10. 10.3109/00365549009023112.View ArticlePubMedGoogle Scholar
- Gerna G, Sarasini A, Zentilin L, Di Matteo A, Miranda P, Parea M, Battaglia M, Milanesi G: Isolation in Europe of 69m-like (serotype 8) human rotavirus strains with either subgroup I or II specificity and a long RNA electropherotype. Arch Virol. 1990, 112: 27-40. 10.1007/BF01348983.View ArticlePubMedGoogle Scholar
- Adah MI, Rohwedder A, Olaleyle OD, Werchau H: Nigerian rotavirus serotypes could not be typed by PCR due to nucleotide mutation at the 3" end of the primer binding site. Arch Virol. 1997, 142: 1881-1887. 10.1007/s007050050206.View ArticlePubMedGoogle Scholar
- Santos N, Lima RCC, Pereira CFA, Gouvea V: Detection Of Rotavirus Types G8 And G10 Among Brazilian Children With Diarrhea. J Clin Microbiol. 1998, 36: 2727-2729.PubMedPubMed CentralGoogle Scholar
- Cunliffe NA, Gondwe JS, Broadhead RL, Molyneux E, Woods PA, Breese JS, Glass RI, Gentsch JR, Hart AC: Rotavirus G and P types in children with acute diarrhoea in Blantyre, Malawi from 1997 to 1998: predominance of novel PG8 strains. J Med Virol. 1999, 57: 308-312. 10.1002/(SICI)1096-9071(199903)57:3<308::AID-JMV15>3.0.CO;2-B.View ArticlePubMedGoogle Scholar
- Matthijnssens J, Rahman M, Yang X, Delbeke T, Arijs J, Kabue JP, Muyembe JJ, Van Ranst M: G8 rotavirus strains isolated in the Democratic Republic of Congo belong to the DS-1 like genogroup. J Clin Microbiol. 2006, 44: 1801-1809. 10.1128/JCM.44.5.1801-1809.2006.View ArticlePubMedPubMed CentralGoogle Scholar
- Iturriza-Gómara M, Kang G, Mammen A, Jana AK, Abraham M, Desselberger U, Brown D, Gray J: Characterization of G10P rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J Clin Microbiol. 2004, 42: 2541-2547. 10.1128/JCM.42.6.2541-2547.2004.View ArticlePubMedGoogle Scholar
- Barril PA, Martinez LC, Giordano MO, Castello AA, Rota RP, Isa MB, Masanchessi G, Ferreyra LJ, Glikmann G, Nates SV: Detection of Group A Human Rotavirus G9 genotype circulating in Còrdoba, Argentina, as early as 1980. J Med Virol. 2006, 78: 1113-1118. 10.1002/jmv.20670.View ArticlePubMedGoogle Scholar
- Fischer TK, Eugen-Olsen J, Pedersen AG, Mølbak K, Böttinger B, Rostgaard K, Nielsen NM: Characterization of Rotavirus strains in a Danish population: high frequency of mixed infections and diversity within the VP4 gene of P strains. J Clin Microbiol. 2005, 43: 1099-1104. 10.1128/JCM.43.3.1099-1104.2005.View ArticlePubMedPubMed CentralGoogle Scholar
- Nielsen NM, Eugen-Olsen J, Aaby P, Mølbak K, Rodrigues A, Fischer TK: Characterization of Rotavirus strains among hospitalised and non-hospitalized children in Guinea-Bissau, 2002. A high frequency of mixed infections with serotype G8. J Clin Microbiol. 2005, 34: 13-21.Google Scholar
- Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M, the Human Rotavirus Vaccine Study Group: Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006, 354: 11-22. 10.1056/NEJMoa052434.View ArticlePubMedGoogle Scholar
- Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM, the Rotavirus Efficacy, Safety Trial (REST) Study Team: Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006, 354: 23-33. 10.1056/NEJMoa052664.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/9/43/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.